% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Gruner:154419,
author = {L. Gruner$^*$ and M. Hoffmeister$^*$ and L. Ludwig and H.
Brenner$^*$},
title = {{E}ffect of {V}arious {I}nvitation {S}chemes on the {U}se
of {F}ecal {I}mmunochemical {T}ests for {C}olorectal
{C}ancer {S}creening: {P}rotocol for a {R}andomized
{C}ontrolled {T}rial.},
journal = {Journal of medical internet research / Research Protocols
Research Protocols [...]},
volume = {9},
number = {4},
issn = {1929-0748},
address = {Toronto},
reportid = {DKFZ-2020-00750},
pages = {e16413},
year = {2020},
note = {#EA:C070#LA:C070#},
abstract = {Fecal occult blood testing has been offered for many years
in the German health care system, but participation rates
have been notoriously low.The aim of this study is to
evaluate the effect of various personal invitation schemes
on the use of fecal immunochemical tests (FITs) in persons
aged 50-54 years.This study consists of a three-armed
randomized controlled trial: (1) arm A: an invitation letter
from a health insurance plan including a FIT test kit, (2)
arm B: an invitation letter from a health insurance plan
including an offer to receive a free FIT test kit by mail
upon easy-to-handle request (ie, by internet, fax, or reply
mail), and (3) arm C: an information letter on an existing
colonoscopy offer (ie, control). Within arms A and B, a
random selection of $50\%$ of the study population will
receive reminder letters, the effects of which are to be
evaluated in a substudy.A total of 17,532 persons aged 50-54
years in a statutory health insurance plan in the southwest
of Germany-AOK Baden-Wuerttemberg-were sent an initial
invitation, and 5825 reminder letters were sent out. The
primary end point is FIT usage within 1 year from receipt of
invitation or information letter. The main secondary end
points include gender-specific FIT usage within 1 year,
rates of positive test results, rates of colonoscopies
following a positive test result, and detection rates of
advanced neoplasms. The study was launched in September
2017. Data collection and workup were completed in fall
2019.This randomized controlled trial will provide important
empirical evidence for enhancing colorectal cancer screening
offers in the German health care system.German Clinical
Trials Register (DRKS) DRKS00011858;
https://bit.ly/2UBTIdt.DERR1-10.2196/16413.},
cin = {C070 / C120 / HD01},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32242518},
doi = {10.2196/16413},
url = {https://inrepo02.dkfz.de/record/154419},
}